Working… Menu

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Locally Advanced and Metastatic Urothelial Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03676946
Recruitment Status : Recruiting
First Posted : September 19, 2018
Last Update Posted : September 26, 2018
Information provided by (Responsible Party):
Lee's Pharmaceutical Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 14, 2020
Estimated Study Completion Date : June 23, 2023